Switch to Jennifer Baker's research page...

2008

1. *Bains LJ, *Baker JHE, Kyle AH, Minchinton AI, Reinsberg SA. Detecting vascular-targeting effects of hypoxic cytotoxin tirapazamine in xenografts using MRI Submitted to Radiation Oncology Biology Physics (2008).
    Request Paper

2. Baker JHE, Lam J, Kyle AH, Sy J, Oliver T, Co S, Dragowska WH, Ramsay E, Anantha M, Ruth TJ, Adam MJ, Yung A, Kozlowski P, Minchinton AI, Ng SSW, Bally MB, Yapp DTT. Irinophore C, a novel nano-formulation of irinotecan, alters tumor vascular function, and enhances the distribution of 5-FU and doxorubicin Submitted to Clinical Cancer Research (2008).
    Request Paper

3. Baker JHE, Lindquist KE, Huxham LA, Kyle AH, Sy JT, Minchinton AI. Direct visualization of heterogeneous extravascular distribution of trastuzumab in human epidermal growth factor receptor type 2 overexpressing xenografts Clinical Cancer Research 14:7 p. 2171-9 (2008).
    [View Abstract - PubMed 18381959]  Request Paper

4. Huxham LA, Kyle AH, Baker JHE, McNicol KL, Minchinton AI. Exploring vascular dysfunction caused by tirapazamine Microvascular Research 75:2 p. 247-55. (2008).
    [View Abstract - PubMed 18023823]  Request Paper

2006

5. Baker JH, Huxham LA, Kyle AH, Lam KK, Minchinton AI. Vascular-specific quantification in an in vivo Matrigel chamber angiogenesis assay. Microvasc Res. 71(2):69-75. Epub 2006 Mar 20. (2006).
    [View Abstract - PubMed 16545400]  Request Paper

6. Huxham LA, Kyle AH, Baker JH, McNicol KL, Minchinton AI. Tirapazamine causes vascular dysfunction in HCT-116 tumour xenografts. Radiother Oncol. 78(2):138-45. Epub 2006 Feb 7. (2006).
    [View Abstract - PubMed 16455148]  Request Paper

2005

7. Tozer GM, Ameer-Beg SM, Baker J, Barber PR, Hill SA, Hodgkiss RJ, Locke R, Prise VE, Wilson I, Vojnovic B. Intravital imaging of tumour vascular networks using multi-photon fluorescence microscopy. Adv Drug Deliv Rev. 57(1):135-52. (2005).
    [View Abstract - PubMed 15518926]  Request Paper

2004

8. Huxham LA, Kyle AH, Baker JH, Nykilchuk LK, Minchinton AI. Microregional effects of gemcitabine in HCT-116 xenografts. Cancer Res. 64(18):6537-41. (2004).
    [View Abstract - PubMed 15374965]  Request Paper

2003

9. Kyle AH, Huxham LA, Baker JH, Burston HE, Minchinton AI. Tumor distribution of bromodeoxyuridine-labeled cells is strongly dose dependent. Cancer Res. 63(18):5707-11. (2003).
    [View Abstract - PubMed 14522888]  Request Paper

2008

1. Baker JHE, Bains L, Reinsberg S, Kyle AH, Methot S, Flannagan E, Minchinton AI. Lower tumour perfusion and permeability in tumours with stronger sensitivity to vascular targeting effects of tirapazamine Tumour Microenvironment Workshop, Miami (2008).
    Request Paper

2007

2. Baker JHE, Bains L, Huxham LAH, Kyle AH, Lindquist KE, Reinsberg S, Minchinton AI. Differential sensitivity to vascular targeting effects of tirapazamine in HCT116 and HT29 xenografts Vascular Targeted Therapies in Oncology (European Society of Hematology) Meeting, Nice, France (2007).
    Request Paper

3. Baker JHE, Sy J, Co S, Yung A, Dragowska W, Ruth T, Adam M, Ng S, Minchinton A, Kozlowski P, Ramsay E, Bally M, Yapp D. . Liposomal CPT-11 changes the vasculature and oxygenation status of HT-29 tumours. Tumour Microenvironment: Progression, Therapy and Prevention Meeting, Florence, Italy (2007).
    Request Paper

4. Jennifer H. E. Baker, Kirstin E. Lindquist, Lynsey A. Huxham, Alastair H. Kyle, . Extravascular distribution of trastuzumab in Her2/neu overexpressing xenografts AACR-NCI-EORTC Conference on Molecular Targets, San Francisco, USA (2007).
    Request Paper

2006

5. Baker JHE, Huxham LAH, Kyle AH, Andersen RJ, Williams DE, Minchinton AI. . Anti-angiogenic activity of Motamine in the Matrigel Chamber Angiogenesis Assay. AACR Annual Meeting, Washington DC (2006).
    Request Paper

6. Baker JHE, Lindquist KE, Huxham LAH, Kyle AH, Sy J, Minchinton AI. . Distribution of Herceptin in tumour xenografts overexpressing HER2/neu. AACR Annual Meeting, Washington DC (2006).
    Request Paper

2005

7. Baker JHE, Huxham LA, Kyle AH, Lam K, Minchinton AI. . A quantitative in vivo Matrigel chamber angiogenesis assay: Anti-angiogenic activity of thalidomide and LL/M27 primary tumours. Tumour Microenvironment Meeting, Oxford, UK (2005).
    Request Paper